Table 2 Primers for constructing JEV-infectious DNA clone

From: The molecular determinants governing the immunogenicity of Japanese encephalitis live attenuated vaccines

Primers

Sequences

F1

5′- TTGGCGCGCCATTTAGGTGACACTATAGAGAAGTTTATCTGTGTGAACTTCTT-3′, AscI sp6 promoter

R1

5′- CCTGG C GCCTGCACAAGCTATGACAAC-3′, KasI

F2

5′- TTGGCGCGCCAATGCAGG C GCCATGAAGTTGTCGAAT-3′, AscI, KasI

R3

5′- GGTCCGGACCAGTCTAGTGACAGATCTGACTC-3′, BspEI, BglII

F4

5′- TGCGGAGTCAGATCTGTCACT-3′, BglII

R4

5′- CATTTTCTGTCCGGAATCGTAG-3′, BspEI

F5

5′- CGCCCCTACGATTCCGGACAGA-3′, BspEI

R6

5′- GGAAAAGGATCCGTGGTTCCAGG-3′, BamHI

F7

5′- ACCACGGATCCTTTTCCTGACTC-3′, BamHI

R8

5′- CCGCTCGAGCGGTGCTCTAGAACGCGTGTATTCCGACGTGATCAGGTG-3′, XhoI, XbaI, MluI, BclI

F9

5′- CACCTGATCACGTCGGAATA-3′, BclI

R10

5′- CCGCTCGAGCCCAAAGCTTCAAACTCTAGAT-3′, XhoI, XbaI

F11

5′- GCTTGGAGCACGGTATCTAGAGTT -3′, XbaI

R11

5′- CCGCTCGAGAGATCCTGTGTTCTTCCTCACCAC-3′, XhoI

Serial nos

Mutations

SA14-14

SA14-14-2

1

E-107

Phenylalanine

Leucine

2

E-138

Lysine

Phenylalanine

3

E-176

Valine

Isoleucine

4

E-177

Alanine

Threonine

5

E-264

Methionine

Lysine

6

E-279

Valine

Alanine

7

E-315

Proline

Serine

  1. Abbreviation: JEV, Japanese encephalitis virus. Underline entities are the restriction enzyme.